{
    "clinical_study": {
        "@rank": "115838", 
        "arm_group": {
            "arm_group_label": "all eligible patients", 
            "description": "Daivobet\u00ae Gel once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this observational study is to document the course of disease and relapse\n      management during treatment with Daivobet\u00ae Gel under consideration of patient`s individual\n      application habits under daily use conditions."
        }, 
        "brief_title": "Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Psoriasis Vulgaris", 
            "Plaque Psoriasis"
        ], 
        "condition_browse": {
            "mesh_term": "Psoriasis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with light to moderate psoriasis vulgaris of trunk and extremities and\n             treatment with Daivobet\u00ae Gel was planned anyway.\n\n          -  Minimum of 3 years diagnosed psoriasis vulgaris.\n\n        Exclusion Criteria:\n\n          -  Previous therapy with Daivobet\u00ae Gel\n\n          -  Systemic therapy of psoriasis vulgaris\n\n          -  Contraindications of Daivobet\u00ae Gel in the German package insert\n\n          -  people that are incapable to give free consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with Psoriasis vulgaris visiting their attending dermatologist in the primary\n        care clinic"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707368", 
            "org_study_id": "DE-Daivobet-longterm-NIS-2012"
        }, 
        "intervention": {
            "arm_group_label": "all eligible patients", 
            "description": "Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance.", 
            "intervention_name": "Daivobet\u00ae Gel", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Betamethasone-17,21-dipropionate", 
                "Betamethasone", 
                "Betamethasone sodium phosphate", 
                "Calcipotriene"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Psoriasis", 
            "Psoriasis vulgaris", 
            "Plaque Psoriasis", 
            "Daivobet\u00ae Gel", 
            "Germany"
        ], 
        "lastchanged_date": "November 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Osnabr\u00fcck", 
                    "country": "Germany", 
                    "state": "Niedersachsen", 
                    "zip": "49078"
                }, 
                "name": "PD Dr. med. Rosenbach"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Course of Psoriasis During Long Term Treatment With Calcipotriol Plus Betamethasone in Gel Formulation", 
        "overall_official": {
            "affiliation": "private practise, D- 49078 Osnabr\u00fcck, Germany", 
            "last_name": "Thomas Rosenberg, PD Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of exacerbations and relapses during one year observation time", 
            "measure": "The course of disease and relapse management during treatment with Daivobet\u00ae Gel under consideration of patient`s individual application habits under daily use conditions.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707368"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Assessment on 6-step scale from \"no visible disease (O)\" to \"very severe disease (5)", 
                "measure": "Physician's global Assessment of psoriasis vulgaris", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Number of participants with serious and non-serious adverse drug reactions, according to organ classes.", 
                "measure": "Side effects", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }
        ], 
        "source": "LEO Pharma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LEO Pharma", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}